Skip to main content
An official website of the United States government

Error message

Could not retrieve the oEmbed resource.

Biology Behind Targeted Therapy for Lymphomas

Dr. Staudt talks about how ibrutinib is a very specific agent that has a high degree of efficacy with only modest side effects in treating the ABC form of Diffuse B-cell Lymphoma

  • Posted: